Zusammenfassung
Noradrenalin, Adrenalin und Dopaminderivate des Katechols (l,2-Dihydroxybenzol) werden im zentralen Nervensystem (ZNS), sympathischen Nerven und Ganglien sowie in den chromaffinen Zellen des Nebennierenmarks (NNM) gebildet. Im ZNS sind Dopamin und Noradrenalin weit verbreitet, während Adrenalin im Gehirn der Säugetiere in relativ niedrigen Konzentrationen gefunden wird. In der Peripherie ist Noradrenalin der Transmitter des postganglionären sympathischen Nervensystems und Dopamin ist als relevanter Regulator an der renalen Durchblutung beteiligt. Adrenalin wird in der Peripherie vor allem in den chromaffinen Zellen des NNM gebildet und freigesetzt.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Averbuch S.D., Steakley C., Young R.C., Gelmann E.P., Goldstein D.S., Stull R., Keiser H.R. (1988) Malignant pheochromocytoma: effective treatment with a combination of cyclophosphymide, voncristine and dacarbazine. Ann Int Med 109: 267–273
Bannister R., Mathias C.J. (1993) Autonomic failure. Oxford Medical Publications, Oxford
Beldjord C., Desclaux-Arramond F., Raffin-Sanson M. et al. (1995) The ret-protooncogene in sporadic pheochromocytomas: Frequent MEN 2-like mutations and new molecular defects. J Clin Endocrinol Metab 80: 2063–2068
Bravo E.L. (1996) Plasma or urinary metanephrines for the diagnosis of pheochromocytoma? That is the question. Ann Int Med 125: 331–332
Canale M.P., Bravo E.L. (1994) Diagnostic specificity of serum chromogranin A for pheochromocytoma in patients with renal dysfunction. J Clin Endocrinol Metab 78: 1139–44
Chen Y., Best J.A., Nagamoto K., Tank A.W. (1996) Regulation of tyrosine hydroxylase gene expression by the ml muscarinic acetylcholine receptor in rat pheochromocytoma cells. Brain Res Mol Brain Res 40: 42–54
Duerr E.M., Gimm O., Neuberg D.S., Kum J.B., Clifford S.C., Toledo S.P., Maher E.R., Dahia P.L., Eng C. (1999) Differences in allelic distribution of two polymorphisms in the VHL-associated gene CUL2 in pheochromocytoma patients without somatic CUL2 mutations. J Clin Endocrinol Metab 84: 3207–3211
Eisenhofer G., Lenders J.W., Linehan W.M., Walther M.M., Goldstein D.S., Keiser H.R. (1999) Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. N Engl J Med 340: 1872–1879
El-Mestikawy S., Glowinski J., Hamon M. (1983) Tyrosine hydroxylase activation in depolarized dopaminergic terminals-involvement of Ca2 +-dependent phosphorylation. Nature 302: 830–832
Kopf D., Bockisch A., Steinert H., Hahn K., Beyer J., Neumann H.P.H., Hensen J., Lehnert H. (1997) Octreotide scintigraphy and catecholamine response to an octreotide challenge in malignant pheochromocytoma. Clin Endocrinol 46: 39–44
Kopf D., Goretzki P.E., Lehnert H. (2000) Clinical management of malignant adrenal tumors. J Cancer Res Clin Oncol 2000, in press
Lehnert H. (1995) Diagnostik und Therapie des malignen Phäochromozytoms. In: Leiehnert H, Kopf D, Hensen J. (Hrsg) Endokrine Tumoren-Jahrestagung der Sektion Angewandte Endokrinologie der Deutschen Gesellschaft für Endokrinologie. Bundesdruckerei Neu-Isenburg, S 157–165
Ligget, S.B. und Raymond, J.R. (1993) Pharmacology and molecular biology of adrenergic receptors. Bailliere’s Clin Endocrinol Metabol vol 7/2: 279–306
Lehnert H. (1998) Regulation of catecholamine synthesizing enzyme gene expression in human pheochromocytoma. Eur J Endocrinol 138: 363–367
Manger T., Piatek S., Klose S., Kopf D., Kunz D., Lehnert H., Lippert H. (1997) Bilaterale laparoskopische Adrenalektomie beim Phäochromozytom. Langenbecks Arch Chir Suppl Kongressbd 382: 37–42
Mathias C.J. (1993) Sympathetic nervous system dis orders in man. Bailliere’s Clin Endocrinol Metab 7: 465–490
Minneman K.P. (1988) α-adrenergic receptor subtypes, inositol phosphates, and sources of cell Ca2+. Pharmacol Rev 40: 87–119
Mulligan L.M., Eng C., Healey C.S. et al. (1994) Specific mutations of the ret proto-oncogene are related to disease phenotype in MEN 2 A and FMTC. Nature Genet 6: 70–74
Mundschenk J., Lehnert H. (1998) Malignant pheochromocytoma. Exp Clin Endocrinol Diabetes 106: 373–376
Neumann H.P., Reincke M., Bender B.U., Elsner R., Janetschek G. (1999) Preserved adrenocortical function after laparoscopic bilateral adrenal sparing surgery for hereditary pheochromocytoma. J Clin Endocrinol Metab 84: 2608–2610
Perlman, R.L. und Chalfie, M. (1977) Catecholamine release from the adrenal medulla. Clin Endocrinol Metab 6: 551–576
Plouin P.F., Catellier G., Fofol I., Corvol P. (1997) Tumor recurrence and hypertension after successful pheochromocytoma operation. Hypertension 29: 1133–1139
Preitner F., Muzzin P., Revelli J.P. et al. (1998) Metabolic response to various beta-adrenoceptor agonists in beta3-adrenoceptor knockout mice: evidence for a new betaadrenergic receptor in brown adipose tissue. Br J Pharmacol 124: 1684–1688
Ruß H., Staust K., Martel F., Gliese M., Schomig E. (1996) The extraneuronal transporter for monoamine transmitters exists in cells derived from human central nervous system glia. Eur J Neurose 8: 1256–1264
Schatz I.J. (1994) Orthostatic hypotension. Clinical diagnosis, testing and treatment. Arch Int Med 144: 1037–1041
Schlumberger M., Gicquel C., Lumbroso J. et al. (1992) Malignant pheochromocytoma: Clinical, biological, histologic and therapeutic data in aseries of 20 patients with distant metastases. J Endocrinol Invest 15: 631–642
Schubert B., VanDongen A.M,. Kirsch G.E., Brown A.M. (1989) Beta-adrenergic inhibition of cardiac sodium channels by dual G-protein pathways. Science 245: 516–519
Shapiro B., Sisson J.C., Lloyd R., Nakajo M., Satterlee W., Beierwalters W.H. (1984) Malignant phaeochromocytoma:clinical, biochemical and scintigraphic characterization. Clin Endocrinol 20: 189–203
Shulkin B.L., Thompson N.W., Shapiro B., Francis I.R., Sisson J.C. (1999) Pheochromocytomas: imaging with 2-(fluorine-18)fluoro-2-deoxy-D-glucose PET. Radiology 212: 35–41
Sisson J.C., Shapiro B., Meyers L. et al. (1987) MIBG to map scintigraphically the adrenergic nervous system in man. J Nucl Med 28: 1625–1636
Trendelenburg U. (1990) The interaction of transport mechanisms and intracellular enzymes in metabolizing systems. J Neural Transm (Suppl 32):3–18
Udenfriend S. (1966) Tyrosine hydroxylase. Pharmacol Rev 18: 43–51
Vargas M.P., Zhuang Z., Wang C., Vortmeyer A., Linehan W.M., Merino M.J. (1997) Loss ofheterozygosity on the short arm of chromosomes 1 and 3 in sporadic pheochromocytoma and extra-adrenal paraganglioma. Hum Pathol 28: 411–415
Webber J., Macdonald I.A. (1993) Metabolic actions of catecholamines in man. Bailliere’s Clin Endocrin Metabol, vol 7/2: 393–414
Winkler H., Sietzen M., Schober M. (1987) The life cyele of catecholamine-storing vesieles. Ann N Y Acad Sci 493: 3–19
Wong D.L., Siddall B., Wang W. (1995) Hormonal control of rat adrenal phenylethanolamine N-methyltransferase. Enzyme activity, the final critical pathway. Neuropsychopharmacology 13: 223–234
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kopf, D., Schulz, C., Lehnert, H. (2001). Katecholamine. In: Nawroth, P.P., Ziegler, R. (eds) Klinische Endokrinologie und Stoffwechsel. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56784-1_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-56784-1_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62970-9
Online ISBN: 978-3-642-56784-1
eBook Packages: Springer Book Archive